Skip to main content
Clinical Trials/NCT01086137
NCT01086137
Completed
Not Applicable

Assessing Salivary Biomarkers for Risk Stratification in Metabolic Syndrome

West Virginia School of Osteopathic Medicine1 site in 1 country102 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
West Virginia School of Osteopathic Medicine
Enrollment
102
Locations
1
Primary Endpoint
Salivary Biomarker Levels
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to investigate the feasibility of using salivary biomarkers to screen for complications of metabolic syndrome including prediabetes.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
December 2011
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kristie Bridges

Associate Professor

West Virginia School of Osteopathic Medicine

Eligibility Criteria

Inclusion Criteria

  • Between the ages of 18 and 65 years
  • Males and females will be included in this study
  • All ethnic backgrounds will be included in this study
  • Acceptable health based on interview and medical history
  • Ability to comply with requirements of the study
  • Ability and willingness to provide signed informed consent

Exclusion Criteria

  • Eating or drinking anything but water within 10 hours of sample collection
  • Autoimmune disease
  • Type 1 diabetes
  • Pregnancy (\< 6 weeks postpartum)
  • History of Sjorgren's Syndrome
  • Dental work within the last two weeks
  • Ongoing or active parasitic, fungal, viral or bacterial infection

Outcomes

Primary Outcomes

Salivary Biomarker Levels

Time Frame: baseline

Study Sites (1)

Loading locations...

Similar Trials